SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,280,000 | -69.8% | 150,000 | -73.9% | 0.01% | -65.6% |
| Q2 2022 | $14,157,000 | -86.6% | 575,000 | -69.3% | 0.03% | -84.1% |
| Q1 2022 | $105,863,000 | +196.3% | 1,875,666 | +225.4% | 0.20% | +214.1% |
| Q4 2021 | $35,728,000 | -26.5% | 576,452 | -24.7% | 0.06% | -33.3% |
| Q3 2021 | $48,590,000 | +4.6% | 765,918 | +35.9% | 0.10% | +5.5% |
| Q2 2021 | $46,435,000 | +11.1% | 563,468 | -0.8% | 0.09% | +7.1% |
| Q1 2021 | $41,783,000 | +96.0% | 567,935 | +93.2% | 0.08% | +84.8% |
| Q4 2020 | $21,321,000 | – | 294,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,831,307 | $272,679,000 | 26.48% |
| Boxer Capital, LLC | 2,075,905 | $117,164,000 | 6.02% |
| Orbimed Advisors | 6,028,307 | $340,238,000 | 5.52% |
| Perceptive Advisors | 4,527,993 | $255,560,000 | 5.12% |
| SPHERA FUNDS MANAGEMENT LTD. | 460,025 | $25,964,000 | 3.67% |
| Affinity Asset Advisors, LLC | 247,000 | $13,941,000 | 2.23% |
| Artal Group S.A. | 850,000 | $47,974,000 | 2.01% |
| Affinity Asset Advisors, LLC | 160,000 | $9,030,000 | 1.44% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,841,799 | $103,951,000 | 1.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 125,000 | $7,055,000 | 1.00% |